Each batch is independently verified to achieve 99%+ purity using High-Performance Liquid Chromatography (HPLC)
Food and Drug Administration) Separately, FDA documentation around the 503A bulks process shows AOD-9604s status has moved around as nominations were withdrawn and advisory committee discussions occurred
BPC-157 peptide therapy may be suitable for adults seeking relief from musculoskeletal pain or injuries, joint concerns, digestive issues, chronic inflammation, or central nervous system (CNS) disorders.8 11 It could also potentially be used for neuroprotection, nerve regeneration, repairing organ damage from substance overdoses, healing lesions, and more.7 However, its again important to reiterate that nearly all of the above potential benefits of BPC-157 have not been demonstrated in human studies or trials
It is only available legally at veterinarian clinics, typically for the treatment for horses
The World Anti-Doping Agency added BPC-157 to its Prohibited List in January 2022 under category S0 (Non-Approved Substances)